TD Waterhouse Canada’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
TD Waterhouse Canada's PFE Position: Q1 2026 in Review
TD Waterhouse Canada reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $2.61M and leaving 677,398 shares worth $19.3M. The position accounts for 0.06% of the portfolio, ranked #192.
TD Waterhouse Canada first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $73.6M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- TD Waterhouse Canada held 677,398 shares of Pfizer worth $19.3M as of Q1 2026.
- TD Waterhouse Canada sold 97,894 Pfizer shares in Q1 2026, an estimated $2.61M.
- Pfizer made up 0.06% of TD Waterhouse Canada's portfolio in Q1 2026, its #192 holding.
- TD Waterhouse Canada first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- TD Waterhouse Canada's Pfizer position peaked at $73.6M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.